Medical cannabis company IM Cannabis Corp IMCNF IMCC, a multi-country operator with presence in Israel and several European countries, announced earlier this week that its German subsidiary will provide IMC branded medical cannabis products to Zur Rose Pharma GmbH over the next year.
Zur Rose Pharma is a large German pharmaceutical wholesaler and distributor licensed for the supply of medical cannabis. It is part of Zur Rose Group AG ZRSEF, Europe’s largest e-pharmacy.
The purchase commitment between Adjupharm GmbH and Zur Rose GmbH is part of a longer-term sales agreement. it marks IMC’s fourth consecutive deal with a German medical cannabis distributor.
“Securing the three-year sales agreement with Zur Rose and its purchase commitment for IMC branded products are part of our growth strategy in the burgeoning German medical cannabis market," IM Cannabis CEO Oren Shuster told Benzinga. “Partnering with a European e-pharmacy powerhouse like Zur Rose also bears the potential for future expansion of the IMC brand presence across the continent as a leading provider of high-quality medical cannabis products."
Photo: Javier Hasse.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.